ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 49 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $105,000 | – | 22,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 62,000 | $216,000 | 0.20% |
| Monashee Investment Management LLC | 187,190 | $651,000 | 0.15% |
| Cedar Wealth Management, LLC | 46,395 | $161,000 | 0.10% |
| BCWM, LLC | 35,100 | $122,000 | 0.06% |
| Tibra Equities Europe Ltd | 149,595 | $521,000 | 0.05% |
| Ahrens Investment Partners LLC | 30,900 | $108,000 | 0.05% |
| ExodusPoint Capital Management, LP | 151,904 | $529,000 | 0.04% |
| Laurion Capital Management LP | 833,400 | $2,900,000 | 0.04% |
| Alpine Global Management, LLC | 33,928 | $118,000 | 0.03% |
| Cornerstone Capital, Inc. | 57,550 | $200,000 | 0.03% |